New study aims to decode heart attack risks by analyzing plaque and immune cells

NCT ID NCT06489119

Recruiting now Knowledge-focused Sponsor: Harbin Medical University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looks at different types of plaque in the arteries of people with coronary artery disease. Researchers will use special imaging to see the plaque and analyze blood cells at a detailed level. The goal is to understand how plaque features relate to immune responses and future heart problems. 350 participants will be followed over time to track major heart events.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could lead to better ways to predict heart attacks by linking plaque features with immune system markers.
What could go wrong: This is an observational study, not a treatment trial. It may not directly change patient care, and results might not apply to all populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary artery disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CORONARY ARTERY DISEASE

Contacts and locations

Locations

China-Japan Union Hospital of Jilin
RECRUITING

Changchun, Jilin, 130033, China
The Second Affiliated Hospital of Harbin Medical University
RECRUITING

Harbin, Heilongjiang, 150081, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.